(1<i>R</i>,2<i>R</i>,6<i>S</i>)-3-Methyl-6-(3-(4-phenylpiperidin-1-yl)prop-1-en-2-yl)cyclohex-3-ene-1,2-diol

Parkinson’s disease (PD) is a progressive neurodegenerative disorder whose primary manifestation is motor dysfunction. Previous research showed that (1<i>R</i>,2<i>R</i>,6<i>S</i>)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol (Prottremine) exhibits potent antiparkinsonian activity in animal mo...

Descripción completa

Detalles Bibliográficos

Autores principales:	Alexandra V. Podturkina, Nikolai S. Li-Zhulanov, Tatyana V. Rybalova, Konstantin P. Volcho, Nariman F. Salakhutdinov
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2025-11-01
Colección:	Molbank
Materias:	monoterpenoids prottremine piperidine antiparkinsonian activity
Acceso en línea:	https://www.mdpi.com/1422-8599/2025/4/M2088
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!